| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |